Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest
May 26th, 2023
1.8K views
This protocol describes a neonatal porcine model of cardiopulmonary bypass (CPB), with circulatory and cardiac arrest as a tool for studying severe brain damage and other complications secondary to CPB.
Overview
This protocol describes a neonatal porcine model of cardiopulmonary bypass (CPB) with circulatory and cardiac arrest, aimed at studying severe brain damage and complications related to CPB.
Key Study Components
Area of Science
- Neuroscience
- Cardiology
- Animal Models
Background
- Mortality rates for children with congenital heart defects have improved, but comorbidities remain common.
- The lab investigates neuro abnormalities post-cardiac surgery.
- This protocol provides a reproducible model for simulating pediatric cardiac surgery.
- It allows testing of various experimental conditions and hypotheses.
Purpose of Study
- To develop a feasible animal model for studying cardiac surgery effects.
- To assess postoperative outcomes more reliably than traditional methods.
- To facilitate research on congenital heart disease and related comorbidities.
Methods Used
- Neonatal piglets are anesthetized and positioned for surgery.
- Peripheral cannulation is performed for CPB setup.
- Cardiac arrest is induced using potassium chloride.
- Postoperative monitoring includes assessing cerebral parameters.
Main Results
- The vessel cannulation and CPB achieved a 92% success rate.
- MRIs showed early brain damage in CPB with cardiac arrest animals.
- Diffusion tensor imaging identified infarction signs more effectively than conventional MRI.
Conclusions
- This model is effective for studying the impacts of CPB on brain health.
- It provides a platform for future research on congenital heart disease.
- The findings may help in developing preventative measures for comorbidities.
Frequently Asked Questions
What is the significance of using a porcine model?
Porcine models closely mimic human physiology, making them ideal for studying cardiac procedures.
How does this model improve upon traditional methods?
It offers a more reliable assessment of postoperative outcomes through peripheral cannulation.
What are the potential applications of this research?
The research can lead to better understanding and treatment of comorbidities in pediatric cardiac patients.
What imaging techniques were used in this study?
MRI and diffusion tensor imaging were utilized to assess brain damage.
How does the model facilitate future research?
It allows for real-time monitoring of cerebral parameters and testing of various hypotheses.
Executive Industry Relevance
Validated pediatric animal models are critical for de-risking translational research in congenital heart disease, particularly for understanding neurological complications post-cardiac surgery. This neonatal piglet model of extracorporeal cardiopulmonary resuscitation after prolonged circulatory arrest enables rigorous hypothesis testing and supports predictive confidence in preclinical neuroprotection strategies. Its reproducibility and adaptability position it as a foundational tool for portfolio triage and mechanistic de-risking in pediatric cardiac R&D.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of neuroprotective hypotheses in a clinically relevant pediatric context.
- Supports mechanistic de-risking by modeling comorbidities associated with cardiac surgery.
- Facilitates functional target validation for interventions aimed at reducing brain injury.
Screening & Assay Development
- Provides a standardized, reproducible platform for evaluating candidate neuroprotective agents.
- Supports quantitative assessment of brain injury using advanced imaging modalities.
- Enables assay development for monitoring cerebral parameters and postoperative outcomes.
Translational & Preclinical Research
- Aligns with disease-relevant pediatric physiology for translational biomarker discovery.
- Ensures continuity from discovery through preclinical validation of neuroprotective strategies.
- Supports risk-adjusted advancement decisions for pediatric cardiac surgery interventions.
Pipeline & Workflow Integration
This model bridges early discovery and preclinical validation, supporting hypothesis-driven research and quantitative outcome measurement in pediatric cardiac surgery contexts.
- Discovery Biology: Enables rigorous testing of neuroprotection and comorbidity mechanisms post-cardiac arrest.
- Screening: Provides reproducible conditions for evaluating intervention efficacy and safety.
- Analytics: Delivers quantitative MRI and diffusion tensor imaging outputs for comparative analysis.
- Translational Research: Maintains disease relevance and supports biomarker alignment for pediatric populations.
- Enterprise Reuse: Offers a flexible, widely applicable platform for diverse experimental conditions and future studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in pediatric neuroprotection research.
- Operational Value: Standardizes procedures for reproducibility and scalability across research teams.
- Strategic Value: Informs go/no-go decisions and enhances capital efficiency in early-stage pediatric R&D.
- Portfolio Impact: Supports risk-adjusted prioritization of neuroprotective and cardiac interventions.
Implementation Considerations
- Requires expertise in pediatric animal surgery and cardiopulmonary bypass techniques.
- Demands access to advanced imaging infrastructure for quantitative brain injury assessment.
- Necessitates cross-team standardization for protocol reproducibility and data comparability.
- Adaptable to various experimental conditions, including temperature and pharmacologic interventions.
- Limitations include anatomical variability and size constraints in neonatal piglets.
Biopharma FAQs
Why is null hypothesis testing critical in piglet CPB models?
Null hypothesis testing in this model enables objective evaluation of neuroprotective interventions and comorbidity mechanisms, supporting robust target validation in pediatric cardiac research. It ensures that observed effects are statistically significant and not due to procedural variability.
How does independent variable isolation enhance CPB outcome studies?
Isolating variables such as arrest duration, temperature, or pharmacologic intervention allows precise attribution of observed brain injury or recovery outcomes, strengthening mechanistic insights and discovery-stage decision making.
What do quantitative MRI and DTI measurements enable in this protocol?
Quantitative MRI and diffusion tensor imaging provide objective, reproducible metrics of brain injury, enabling comparative analysis across experimental groups and supporting translational biomarker development.
Why are replication requirements important for cross-functional teams using this model?
Replication ensures that findings are robust and transferable across research teams, facilitating cross-functional collaboration and standardization in multi-site pediatric cardiac studies.
What statistical analysis capabilities are needed before implementing piglet CPB studies?
Teams must be equipped to perform rigorous statistical analyses of imaging and physiological data, ensuring that experimental outcomes are interpretable and actionable for portfolio advancement decisions.
